{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Escape&page=3", "query": { "intervention": "Escape", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 82, "total_pages": 9, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Escape&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Escape&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-19T21:27:34.218Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00265096", "title": "A Study of the Safety and Efficacy of Golimumab in Patients With Active Psoriatic Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Arthritis, Psoriatic" ], "interventions": [ { "name": "golimumab", "type": "BIOLOGICAL" }, { "name": "Placebo; golimumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Centocor, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 407, "start_date": "2005-12", "completion_date": "2012-01", "has_results": true, "last_update_posted_date": "2013-07-19", "last_synced_at": "2026-10-19T21:27:34.218Z", "location_count": 18, "location_summary": "Huntsville, Alabama • La Jolla, California • Upland, California + 15 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "La Jolla", "state": "California" }, { "city": "Upland", "state": "California" }, { "city": "Aventura", "state": "Florida" }, { "city": "Coeur d'Alene", "state": "Idaho" } ], "official_url": "https://clinicaltrials.gov/study/NCT00265096" }, { "nct_id": "NCT02505542", "title": "Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Axial Spondyloarthrithis", "Ankylosing Spondylitis" ], "interventions": [ { "name": "Certolizumab Pegol", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "UCB BIOSCIENCES GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 736, "start_date": "2015-07", "completion_date": "2019-04", "has_results": true, "last_update_posted_date": "2020-12-17", "last_synced_at": "2026-10-19T21:27:34.218Z", "location_count": 16, "location_summary": "Glendale, Arizona • Mesa, Arizona • Phoenix, Arizona + 13 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Palm Desert", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02505542" }, { "nct_id": "NCT05928247", "title": "Manualized Assessment and Treatment Model of Challenging Behavior", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Problem Behavior", "Aggression", "Self-Injury" ], "interventions": [ { "name": "Functional Communication Training (FCT)", "type": "BEHAVIORAL" }, { "name": "Non-Contingent Reinforcement (NCR)", "type": "BEHAVIORAL" }, { "name": "Competing Items and Response Blocking", "type": "BEHAVIORAL" }, { "name": "Research Units in Behavioral Intervention (RUBI) protocol", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Rutgers, The State University of New Jersey", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "3 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "3 Years to 17 Years" }, "enrollment_count": 30, "start_date": "2026-12-31", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-05-08", "last_synced_at": "2026-10-19T21:27:34.218Z", "location_count": 1, "location_summary": "Somerset, New Jersey", "locations": [ { "city": "Somerset", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05928247" }, { "nct_id": "NCT03410992", "title": "A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Plaque Psoriasis", "Moderate to Severe Chronic Plaque Psoriasis", "Psoriatic Arthritis" ], "interventions": [ { "name": "Bimekizumab", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "UCB Biopharma SRL", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 435, "start_date": "2018-02-05", "completion_date": "2020-01-07", "has_results": true, "last_update_posted_date": "2026-04-15", "last_synced_at": "2026-10-19T21:27:34.218Z", "location_count": 20, "location_summary": "San Diego, California • Santa Monica, California • Fort Myers, Florida + 15 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Fort Myers", "state": "Florida" }, { "city": "Sandy Springs", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03410992" }, { "nct_id": "NCT01823276", "title": "Effect of Tyrosine on Behavioral, Physiological and Nutritional Status During Survive, Evade, Resist, Escape (SERE) School", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Response to Severe Stress" ], "interventions": [ { "name": "Tyrosine-Containing Bar", "type": "OTHER" }, { "name": "Placebo Bar", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "United States Army Research Institute of Environmental Medicine", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "39 Years", "sex": "MALE", "summary": "18 Years to 39 Years · Male only" }, "enrollment_count": 73, "start_date": "2013-05", "completion_date": "2013-08", "has_results": false, "last_update_posted_date": "2014-05-21", "last_synced_at": "2026-10-19T21:27:34.218Z", "location_count": 1, "location_summary": "Fort Bragg, North Carolina", "locations": [ { "city": "Fort Bragg", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01823276" }, { "nct_id": "NCT00264550", "title": "An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Golimumab 100 mg", "type": "DRUG" }, { "name": "Golimumab 50 mg", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Placebo injection", "type": "DRUG" }, { "name": "Placebo capsules", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Centocor, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 444, "start_date": "2005-12", "completion_date": "2012-05", "has_results": true, "last_update_posted_date": "2014-04-29", "last_synced_at": "2026-10-19T21:27:34.218Z", "location_count": 13, "location_summary": "Mobile, Alabama • Palo Alto, California • Pasadena, California + 10 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Palo Alto", "state": "California" }, { "city": "Pasadena", "state": "California" }, { "city": "Upland", "state": "California" }, { "city": "Ormond Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00264550" }, { "nct_id": "NCT01791153", "title": "An Efficacy and Safety Study of Tocilizumab (RoActemra/Actemra) in Participants With Giant Cell Arteritis (GCA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Giant Cell Arteritis" ], "interventions": [ { "name": "Tocilizumab", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Tocilizumab Placebo", "type": "DRUG" }, { "name": "Prednisone Placebo", "type": "DRUG" }, { "name": "Corticosteroids", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 251, "start_date": "2013-07-22", "completion_date": "2018-06-04", "has_results": true, "last_update_posted_date": "2020-02-06", "last_synced_at": "2026-10-19T21:27:34.218Z", "location_count": 14, "location_summary": "Los Angeles, California • Boca Raton, Florida • Sarasota, Florida + 10 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Boca Raton", "state": "Florida" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Paducah", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT01791153" }, { "nct_id": "NCT06273904", "title": "Modulating Escape Using Focused Ultrasound", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Anxiety Disorders" ], "interventions": [ { "name": "Active transcranial focused ultrasound (tFUS)", "type": "DEVICE" }, { "name": "Sham transcranial focused ultrasound (tFUS)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Medical University of South Carolina", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 40, "start_date": "2024-05-20", "completion_date": "2027-01", "has_results": false, "last_update_posted_date": "2025-10-14", "last_synced_at": "2026-10-19T21:27:34.218Z", "location_count": 1, "location_summary": "Charleston, South Carolina", "locations": [ { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06273904" }, { "nct_id": "NCT05011864", "title": "Integrated Tele-Behavioral Activation and Fall Prevention for Low-income Homebound Seniors With Depression", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Depression, Unipolar", "Fall" ], "interventions": [ { "name": "Behavioral Activation", "type": "BEHAVIORAL" }, { "name": "Fall Prevention", "type": "BEHAVIORAL" }, { "name": "Telephone support", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "University of Texas at Austin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "50 Years to 100 Years" }, "enrollment_count": 320, "start_date": "2021-11-01", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2024-01-09", "last_synced_at": "2026-10-19T21:27:34.218Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05011864" }, { "nct_id": "NCT01172938", "title": "Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "Apremilast 20mg", "type": "DRUG" }, { "name": "Apremilast 30mg", "type": "DRUG" }, { "name": "Placebo + 20 mg Apremilast", "type": "DRUG" }, { "name": "Placebo + 30 mg Apremilast", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 504, "start_date": "2010-06-02", "completion_date": "2016-10-27", "has_results": true, "last_update_posted_date": "2020-06-19", "last_synced_at": "2026-10-19T21:27:34.218Z", "location_count": 27, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • La Jolla, California + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Upland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01172938" } ] }